Literature DB >> 18925608

Leptin induces phagocytosis of apoptotic bodies by hepatic stellate cells via a Rho guanosine triphosphatase-dependent mechanism.

Joy X Jiang1, Kenichiro Mikami, Vijay H Shah, Natalie J Torok.   

Abstract

UNLABELLED: Leptin, a profibrogenic cytokine, plays an important role in the development of non-alcoholic steatohepatitis. Leptin also regulates immune responses, including macrophage phagocytic activity. Stellate cells are key elements in liver fibrogenesis, and previously we have demonstrated that phagocytosis of apoptotic bodies by stellate cells is profibrogenic. To study the effects of leptin on the phagocytic activity of hepatic stellate cells, we exposed both LX-2 cells and primary stellate cells to leptin, and we have observed increased phagocytic activity. In stellate cells isolated from Zucker (fa/fa) rats, the rate of phagocytosis was significantly decreased. To investigate the mechanism by which leptin induces phagocytosis, we focused on the role of Rho-guanosine triphosphate (GTP)-ases. We found that leptin induced the PI3K-dependent activation of Rac1, and that nicotinamide adenine dinucleotide phosphate, reduced form (NADPH) oxidase activation was also implicated in this process. Leptin also induced RhoA activation and translocation to the phagosomes. Expression of the constitutive active Rac1 and RhoA both increased the phagocytic rate, whereas inhibition of the Rho-dependent kinase decreased the phagocytic activity.
CONCLUSION: We describe a novel role of leptin in the fibrogenic process, the induction of phagocytosis of apoptotic bodies by hepatic stellate cells. The data provide strong evidence of a Rho-GTPase-mediated regulation of the cytoskeleton during stellate cell phagocytosis. Leptin-mediated phagocytic activity of stellate cells therefore could be an important mechanism responsible for progression of fibrosis in non-alcoholic steatohepatitis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18925608      PMCID: PMC2596754          DOI: 10.1002/hep.22515

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  30 in total

Review 1.  Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury.

Authors:  S L Friedman
Journal:  J Biol Chem       Date:  2000-01-28       Impact factor: 5.157

2.  Opposite effects of rho family GTPases on engulfment of apoptotic cells by macrophages.

Authors:  Michio Nakaya; Masato Tanaka; Yasutaka Okabe; Rikinari Hanayama; Shigekazu Nagata
Journal:  J Biol Chem       Date:  2006-01-26       Impact factor: 5.157

3.  Rewiring cellular morphology pathways with synthetic guanine nucleotide exchange factors.

Authors:  Brian J Yeh; Robert J Rutigliano; Anrica Deb; Dafna Bar-Sagi; Wendell A Lim
Journal:  Nature       Date:  2007-05-21       Impact factor: 49.962

4.  Leptin in hepatic fibrosis: evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice.

Authors:  Neeraj K Saxena; Kazuo Ikeda; Don C Rockey; Scott L Friedman; Frank A Anania
Journal:  Hepatology       Date:  2002-04       Impact factor: 17.425

5.  Sustained activation of Rac1 in hepatic stellate cells promotes liver injury and fibrosis in mice.

Authors:  Steve S Choi; Jason K Sicklick; Qi Ma; Liu Yang; Jiawen Huang; Yi Qi; Wei Chen; Yin-Xiong Li; Pascal J Goldschmidt-Clermont; Anna Mae Diehl
Journal:  Hepatology       Date:  2006-11       Impact factor: 17.425

6.  A selective ROCK inhibitor, Y27632, prevents dimethylnitrosamine-induced hepatic fibrosis in rats.

Authors:  S Tada; H Iwamoto; M Nakamuta; R Sugimoto; M Enjoji; Y Nakashima; H Nawata
Journal:  J Hepatol       Date:  2001-04       Impact factor: 25.083

7.  Role of alphavbeta6 integrin in acute biliary fibrosis.

Authors:  Bruce Wang; Brian M Dolinski; Noriko Kikuchi; Diane R Leone; Marion G Peters; Paul H Weinreb; Shelia M Violette; D Montgomery Bissell
Journal:  Hepatology       Date:  2007-11       Impact factor: 17.425

8.  Integrin alphavbeta6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies.

Authors:  Yury Popov; Eleonora Patsenker; Felix Stickel; Jessica Zaks; K Ramakrishnan Bhaskar; Gerald Niedobitek; Armin Kolb; Helmut Friess; Detlef Schuppan
Journal:  J Hepatol       Date:  2008-01-14       Impact factor: 25.083

9.  Two distinct cytoplasmic regions of the beta2 integrin chain regulate RhoA function during phagocytosis.

Authors:  Agnès Wiedemann; Jayesh C Patel; Jenson Lim; Andy Tsun; Yvette van Kooyk; Emmanuelle Caron
Journal:  J Cell Biol       Date:  2006-03-27       Impact factor: 10.539

10.  Leptin promotes invasiveness of kidney and colonic epithelial cells via phosphoinositide 3-kinase-, rho-, and rac-dependent signaling pathways.

Authors:  S Attoub; V Noe; L Pirola; E Bruyneel; E Chastre; M Mareel; M P Wymann; C Gespach
Journal:  FASEB J       Date:  2000-11       Impact factor: 5.191

View more
  19 in total

1.  Hepatocyte apoptotic bodies encasing nonstructural HCV proteins amplify hepatic stellate cell activation: implications for chronic hepatitis C.

Authors:  R K Gieseler; G Marquitan; M Schlattjan; J-P Sowa; L P Bechmann; J Timm; M Roggendorf; G Gerken; S L Friedman; A Canbay
Journal:  J Viral Hepat       Date:  2010-08-15       Impact factor: 3.728

2.  The hydrolysis of striatal adenine- and guanine-based purines in a 6-hydroxydopamine rat model of Parkinson's disease.

Authors:  Jean Pierre Oses; Cristiane Batassini; Daniela Pochmann; Ana Elisa Böhmer; Fernanda Cenci Vuaden; Roberta Bristot Silvestrin; Alcyr Oliveira; Carla Denise Bonan; Maurício Reis Bogo; Diogo Onofre Souza; Luis Valmor Cruz Portela; João José de Freitas Sarkis; Tadeu Mello e Souza
Journal:  Neurochem Res       Date:  2010-11-04       Impact factor: 3.996

Review 3.  Dysregulation of redox pathways in liver fibrosis.

Authors:  Natalie J Torok
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-08-25       Impact factor: 4.052

4.  NADPH Oxidases in Chronic Liver Diseases.

Authors:  Joy X Jiang; Natalie J Török
Journal:  Adv Hepatol       Date:  2014-11-30

5.  Reduced nicotinamide adenine dinucleotide phosphate oxidase 2 plays a key role in stellate cell activation and liver fibrogenesis in vivo.

Authors:  Joy X Jiang; Senthil Venugopal; Nobuko Serizawa; Xiangling Chen; Fiona Scott; Yong Li; Roger Adamson; Sridevi Devaraj; Vijay Shah; M Eric Gershwin; Scott L Friedman; Natalie J Török
Journal:  Gastroenterology       Date:  2010-06-01       Impact factor: 22.682

6.  Galectin-3 modulates phagocytosis-induced stellate cell activation and liver fibrosis in vivo.

Authors:  Joy X Jiang; Xiangling Chen; Daniel K Hsu; Kornelia Baghy; Nobuko Serizawa; Fiona Scott; Yoshikazu Takada; Yoko Takada; Hiroo Fukada; Jenny Chen; Sridevi Devaraj; Roger Adamson; Fu-Tong Liu; Natalie J Török
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-12-08       Impact factor: 4.052

Review 7.  Hepatic stellate cells, liver innate immunity, and hepatitis C virus.

Authors:  Yizhong Wang; Jieliang Li; Xu Wang; Min Sang; Wenzhe Ho
Journal:  J Gastroenterol Hepatol       Date:  2013-08       Impact factor: 4.029

Review 8.  Apoptosis as a mechanism for liver disease progression.

Authors:  Maria Eugenia Guicciardi; Gregory J Gores
Journal:  Semin Liver Dis       Date:  2010-10-19       Impact factor: 6.115

9.  Liver fibrosis causes downregulation of miRNA-150 and miRNA-194 in hepatic stellate cells, and their overexpression causes decreased stellate cell activation.

Authors:  Senthil K Venugopal; Joy Jiang; Tae-Hun Kim; Yong Li; Si-Si Wang; Natalie J Torok; Jian Wu; Mark A Zern
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-11-05       Impact factor: 4.052

10.  Pathophysiology of NASH: perspectives for a targeted treatment.

Authors:  Fabio Marra; Sophie Lotersztajn
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.